Naloxone Rescue for Opioid Reversal

Size: px
Start display at page:

Download "Naloxone Rescue for Opioid Reversal"

Transcription

1 Naloxone Rescue for Opioid Reversal Shannon Panther, PharmD, BCACP Washington State University October 8, 2015 Disclosures No relationships to disclose Intranasal use of naloxone is off label Objectives 1. Discuss the overdose epidemic on a national scale compare to local numbers 2. Recall the mechanism of action of naloxone and the effects on the body 3. Outline the Substance Abuse and Mental Health Services Administration (SAMHSA) Opioid Reversal Toolkit for training a rescuer 4. Describe the steps for responding to an overdose 5. Practice administration technique with a demonstration kit as part of a small group activity 1

2 Visualize Who comes to mind when you think about a person at risk for overdose? National Statistics Each day 46 people die from prescription opioid overdose About 2 per hour 2010, reported 1:20 people ( 12 years old) misused prescription opioids Majority Caucasian males Female numbers rising Source: CDC 1,2 Image source: CDC. Injury Prevention & Control: Prescription Drug Overdose

3 Opioid Prescriptions Sold (2010) Image source: CDC. Vital Signs Overdose Death Rate (2008) Image source: CDC. Vital Signs Overtime See Parallel Rates Image source: CDC. Injury Prevention & Control: Prescription Drug Overdose

4 Oregon Statistics Death rates due to overdose Heroin: 2012, 16% Prescription: 2013, 38% 1 death, for every 1,900 methadone and 20,300 other opioids prescribed Prescribing 2013, PDMP data shows 1:4 Oregonians prescribed opioids Misuse 2012 to 2013, est. 212,000 Oregonians non medically used Source: CD Summary 6, OHA 7 Pharmacology of Naloxone MOA of naloxone is not fully understood Strong antagonist of mu receptor Also kappa and delta Metabolized by liver Half life 30 to 81 min Requires more than one dose Stability Exposure to temperature extremes, shelf life Source: Clinical Pharmacology 8 Antagonism Image source: copeaustralia.com. Why Naloxone

5 Safety Safety profile of naloxone is remarkably high Low doses and titrate to effect Higher doses for rapid reversal can be unpleasant Not life threatening No opioid = no effect Source: Clinical Pharmacology 8 Options for Administration IV = 1 2 min IM/SQ = 2 5 min IN = 8 13 min In the field response, retrospective analysis by Robertson TM, et al. Bloodborne pathogen risk Source: Robertson 10, Teleflex 11 Auto injector 0.4 mg/0.4 ml IM or SC Anterolateral aspect of thigh, through clothing Single use ~$600, 2 doses and trainer Source: Evzio PI, Pharmacist s Letter, Evzio website 12,13,14 5

6 Prescriber Role Team up PMP Consider non opioid for mild, or ER form that cannot be abused Limit quantities Consider co prescribing naloxone Source: CDC 2, SAMHSA 15 Laws Rescuer must complete Naloxone Training and receive certificate Physician or NP (supervising professional) oversees training program Presence not required Training done by public health authority, entity or individuals who provide services to those who take opiates In compliance with supervising professional and protocols of OHA Immunity from civil liability for action or administration SB 839 immunity for contacting medical services Source: Oregon Statutes 16, Rules 17,18 Certificate 6

7 Pharmacy Upon presenting certificate Create hardcopy, using supervising professional information Create kit labeled with trainee name, trainer or supervising professional name and statement For use in Oregon Opiate Overdose Treatment Program Source: Oregon Statutes 16, Rules 17,18 Steps for Training Responders Review overdose and risk factors for prescribed and recreational use Tailor to rescuer need Review overdose prevention techniques SAMHSA action plan Source: SAMHSA 15 Risk Factors for Overdose Opioid naïve or changing to different drug Period of sobriety Health changes Prior overdose Mixing with other CNS depressants Unknown strength or quality Using alone Source: Chapman 19 7

8 Overdose Prevention Know tolerance, use as prescribed Do not mix multiple CNS depressants Know the strength/quality Do not use alone Source: Chapman 19 Fact or Fiction Getting high with prescription drugs is safer Using a friends prescription is not abusing Most overdoses occur when substances are mixed Most ODs take up to an hour It is best to let someone sleep it off A cold shower will wake them up They can walk it off Only new users OD Source: Overdose Facts and Myths 20 Signs and Symptoms of an Overdose Opioids Stop breathing Stimulants Heart stops Seizures Stroke 8

9 Recognize the Risk Unresponsive to yelling or sternal rub Slow or no breathing Snoring/gurgling Turning blue (esp. lips and fingernails) Slow pulse Image source: eatingintuitively.com SAMHSA Five Steps for Response 1. Check for signs of opioid overdose 2. Call for help 3. Rescue breathing 4. Naloxone 5. Monitor Step 1: Check for Overdose Slow/stopped breathing, gurgling/snoring Pale, clammy skin Limp body Blue lips of fingernails Cannot wake with shouting With, or without pulse 9

10 Access similar to CPR Try to arouse Rescue position Image source: Stopoverdose.org Opiate Safety Education Brochure Step 2: Get Help Call 911 First response need to arrive 2 doses of naloxone Required by law for immunity (WA, OR?) State to 911 operator someone is not breathing Give address of location Image source: alpabetworld.wordpress.com. Telephone Step 3: Breathing Overdose suppresses respiratory center of brain (µ receptor) Does not stop pulse Need to assist with breathing, oxygen in blood Verify airway is clear Head tilt, chin life Pinch nose closed Give 2 breaths Verify chest rises, avoid stomach bloating Continue 1 breath every 5 sec Image source: Photobucket.com. Rescue Breathing

11 Step 4: Naloxone Administer with known or suspected overdose Duration of action min May require more than 1 dose after 5 min Continue rescue breathing Be ready to move away quickly if patient is combative Be ready to comfort patient, rescue position Image source: Baristanet.com. Essex County Police Supplied with Kits to Prevent Heroin Overdoses Step 5: Monitor Remain with patient until EMTs arrive Patient will need hospital monitoring 11

12 Assembly Image sources: harmreduction.org. Administer Naloxone. 2015, and intranasal.net. Intranasal Naloxone Oregon Resources Multnomah County Health Department Videos on IM and IN administration Opiate Training Protocol Statement of Completed Training Available on website: MSTraumaSystems/Pages/Naloxone Training Protocol.aspx Practice with Demo Kit 12

13 References 1. CDC: Vital Signs Opioid Painkiller Prescribing. Atlanta: Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention. c2014 [cited 2015 June 10]. Available from: prescribing/. 2. CDC: Prescription Painkiller Overdoses in the US. Atlanta: Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention; c2011 [cited 2013 Dec 2]. Available from: 3. CDC: Prescription Drug Overdose Data. Atlanta: Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention; c2015 [cited 2015 June 10]. Available from: 4. CDC: Prescription Painkiller Overdoses in the US. Atlanta: Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention; c2011 [cited 2013 Dec 2]. Available from: 5. CDC: Data Overview. Atlanta: Centers for Disease Control and Prevention, Division of Unintentional Injury Prevention. C2015. [cited 2015 June 10]. Available from: 6. Drug Overdose in Oregon. CD Summary Sept 9; 63, Oregon Health Authority. Prescription Drug Poisoning/Overdose in Oregon Apr 24. [cited 2015 June 9]. 8. Naloxone. Clinical Pharmacology. Goldstandard. [cited 2013 Dec 13]. Available from: ip.com/default.aspx Robertson TM, et al. Intranasal Naloxone is a Viable Alternative to Intravenous Naloxone for Prehospital Narcotic Overdose. Prehosp Emerg Care 2009; 13: LMA MAD Nasal Intranasal Mucosal Atomization Device. Teleflex. Research Triangle Park, NC Evzio [package insert]. Richmond, VA, Kaleo; PL Detail Document, Evzio (Naloxone) for Opioid Overdose: FAQs. Pharmacist s Letter/Prescriber s Letter. July Evzio. Kaleo Dec [cited 2015 June 8]. Available from: evzio.com. 15. Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) Rockville, MD: Substance Abuse and Mental Health Services Administration, Opiate Overdose, ORS (2013). 17. Distribution of Emergency Medication, OAR Opiate Overdose, OAR through Chapman L. Opioid Overdose Risk Factors Ontario; OHRDP Aug 26 [cited 2013 Dec 13]. Available from: overdose risk factors/. 20. Nonmedical Use of Prescription Drugs Myths vs. Facts. Elks National Foundation, Inc. Chicago. [cited 2014 Feb 13]. Available from: 13

OPIOID OVERDOSE PREVENTION ORIENTATION WHAT ARE OPIOIDS AND HOW LONG DO THEY WORK? Duration of Action of Opioids

OPIOID OVERDOSE PREVENTION ORIENTATION WHAT ARE OPIOIDS AND HOW LONG DO THEY WORK? Duration of Action of Opioids OPIOID OVERDOSE PREVENTION ORIENTATION There has been an alarming increase in the incidence of deaths caused by opioid overdose (prescription and non- prescription) in the United States. Enhanced educational

More information

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL Purpose: To reduce morbidity and mortality from opioid overdose. Policy: Under

More information

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina

More information

Naloxone treatment of opioid overdose

Naloxone treatment of opioid overdose Naloxone treatment of opioid overdose Opioids Chemicals that act in the brain to relieve pain, often use to suppress cough, treat addiction, and provide comfort After prolonged use of opioids, increasing

More information

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION 1.0 Purpose OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION This is a DESC internal operational policy and procedure document [effective date: 06/26/2015] Greg Jensen, Director of Administrative Services

More information

Opioid Overdose Prevention Guidelines for Training Responders

Opioid Overdose Prevention Guidelines for Training Responders Opioid Overdose Prevention Guidelines for Training Responders Oct 31, 2006 OD Oct 31, 2006 Opioid Overdose Prevention Guidelines for Training Responders BACKGROUND Introduction Opioid overdose is a serious

More information

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates.

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates. OVERDOSE MANAGEMENT PROTOCOL - NALOXONE/NARCAN TRAINING This training is designed to teach you about one action you can take in case of an overdose of opiates. This training program will not make you a

More information

P U B L I C H E A L T H A D V I S O R Y

P U B L I C H E A L T H A D V I S O R Y The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph

More information

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Alexander Y. Walley, MD, MSc Director, Addiction Medicine Fellowship and Addiction Medicine Consult Service

More information

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E

OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E OVERDOSE EDUCATION & NALOXONE DISTRIBUTION (OEND) IN MICHIGAN P A M E L A L Y N C H, L L M S W, C A A D C W H O S O E V E R C O L L A B O R A T I V E Sales of opioids: Michigan is above the median in

More information

PRESCRIPTION PAINKILLER OVERDOSES

PRESCRIPTION PAINKILLER OVERDOSES IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

Opioid Overdose TOOLKIT: Five Essential Steps for First Responders

Opioid Overdose TOOLKIT: Five Essential Steps for First Responders S A M H S A Opioid Overdose TOOLKIT: Five Essential Steps for First Responders TABLE OF CONTENTS FIVE ESSENTIAL STEPS FOR FIRST RESPONDERS Step 1: Call for Help (Dial 911) 3 Step 2: Check for Signs of

More information

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015 Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol New Mexico Pharmacists Association & Project ECHO 2014 This training fulfills the educational requirement for pharmacists in

More information

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING

RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING RULES AND REGULATIONS PERTAINING TO OPIOID OVERDOSE REPORTING [R23-1-OPOIDR] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH April 2014 (E) COMPILER S NOTES: Proposed Additions: The

More information

GD-112-PHS-EMS: Curriculum for Law Enforcement/EMT Administration of Naloxone in the Pre-Hospital Setting

GD-112-PHS-EMS: Curriculum for Law Enforcement/EMT Administration of Naloxone in the Pre-Hospital Setting STATE OF ARIZONA EMERGENCY MEDICAL SERVICES AND TRAUMA SYSTEM Curriculum for Law Enforcement/EMT Administration of Naloxone in the Course Description This course is designed to provide instruction in a

More information

International Overdose Awareness Day August 31, 2015

International Overdose Awareness Day August 31, 2015 International Overdose Awareness Day August 31, 2015 Statewide TASC Substance Abuse Evaluators Educational Presentation Jayne Cavanaugh, New Jersey Drug Courts Prevalence of Overdose Deaths per Centers

More information

OPIOID OVERDOSE AVERTED: NALOXONE-FRIENDLY ZONES SAVE LIVES. Carl Scroggins, CADC, QHEIC, EMT

OPIOID OVERDOSE AVERTED: NALOXONE-FRIENDLY ZONES SAVE LIVES. Carl Scroggins, CADC, QHEIC, EMT OPIOID OVERDOSE AVERTED: NALOXONE-FRIENDLY ZONES SAVE LIVES Carl Scroggins, CADC, QHEIC, EMT For the audio portion of this webinar, you have two options. 1. Listen through your computer speakers. Just

More information

Irish Poet, Rev John Donne

Irish Poet, Rev John Donne No man is an island entire of itself; any man's death diminishes me, because I am involved in mankind therefore never send to know for whom the bell tolls; it tolls for thee. Irish Poet, Rev John Donne

More information

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES 1 DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES PURPOSE To provide guidelines for staff response when a client is found unconscious or not breathing. APPLICABILITY

More information

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century

Marijuana: The changing public opinion 5/12/2014. Mother s little helper: Prescription drug abuse in the 21 st century Mother s little helper: Prescription drug abuse in the 21 st century Carol Falkowski CEO and Founder Drug Abuse Dialogues St. Paul, Minnesota www.drugabusedialogues.com More kids smoke marijuana than smoke

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

Objectives. Background

Objectives. Background Development and Implementation of a Pharmacist-Managed Intranasal Naloxone Distribution Program in a Veterans Affairs Healthcare Facility and Associated Community Clinics Innovative Practices Award Finalist

More information

Education. The Council of Southeast Pennsylvania, Inc. Overdose Prevention and. Education Advisory Board

Education. The Council of Southeast Pennsylvania, Inc. Overdose Prevention and. Education Advisory Board Overdose Prevention and Education The Council of Southeast Pennsylvania, Inc. Overdose Prevention and Education Advisory Board Outline What is an Overdose? What drugs are we talking about? Risk Factors

More information

Naloxone Distribution for Opioid Overdose Prevention

Naloxone Distribution for Opioid Overdose Prevention Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,

More information

Overdose Response Training

Overdose Response Training Overdose Response Training In collaboration with the Massachusetts Department of Public Health, Bureau of Substance Abuse Services and Office of HIV/AIDS The Overdose Problem National & regional drug threat

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Transcript: DMHAS Overdose Responder Training

Transcript: DMHAS Overdose Responder Training Transcript: DMHAS Overdose Responder Training #1 TITLE SLIDE. #2 INTRODUCTION AND PURPOSE Welcome to Overdose Responder training presented by the NJ Department of Human Services / Division of Mental Health

More information

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii. THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature

More information

Prescription Opioid Overdose & Misuse in Oregon

Prescription Opioid Overdose & Misuse in Oregon Prescription Opioid Overdose & Misuse in Oregon Mel Kohn, MD MPH Public Health Director and State Public Health Officer Oregon Health Authority Oregon In-State Policy Workshop NGA Policy Academy: Reducing

More information

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name.

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. Welcome! 1 This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. 2 Definitive treatment for an opioid or opiate overdose

More information

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015** Disclaimer This presentation was created to assist in the education of EMTs in Naloxone administration.

More information

Massachusetts Department of Public Health Opioid Overdose Education and Naloxone Distribution. MDPH Naloxone pilot project Core Competencies

Massachusetts Department of Public Health Opioid Overdose Education and Naloxone Distribution. MDPH Naloxone pilot project Core Competencies Massachusetts Department of Public Health Opioid Overdose Education and Naloxone Distribution MDPH Naloxone pilot project Core Competencies Acknowledgements: Thank you to the Boston Public Health Commission

More information

Substance Use: Addressing Addiction and Emerging Issues

Substance Use: Addressing Addiction and Emerging Issues MODULE 6: SUBSTANCE USE: ADDRESSING ADDICTION AND EMERGING ISSUES Substance Use: Addressing Addiction and Emerging Issues Martha C. Romney, RN, MS, JD, MPH Assistant Professor Jefferson School of Population

More information

Medication-Assisted Treatment for Opioid Addiction

Medication-Assisted Treatment for Opioid Addiction Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid

More information

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition

Testimony on Opioid Overdose Prevention. Daniel Raymond, Policy Director, Harm Reduction Coalition Testimony on Opioid Overdose Prevention Daniel Raymond, Policy Director, Harm Reduction Coalition Presented on March 25, 2014 to the House Appropriations Subcommittee on Labor, Health and Human Services,

More information

Overdose Prevention and Management in Opioid Treatment Programs

Overdose Prevention and Management in Opioid Treatment Programs Overdose Prevention and Management in Opioid Treatment Programs AATOD 2010 1:30pm Tuesday, October 26, 2010 Moderator: Amina Chaudhry Faculty: Melinda Campopiano Maya Doe-Simkins Alexander Y. Walley Disclosures

More information

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management

Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Prescription Opioid Addiction and Chronic Pain: Non-Addictive Alternatives To Treatment and Management Dr. Barbara Krantz Medical Director Diplomate American Board of Addiction Medicine 1 Learning Objectives

More information

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Epidemiology. Background 3/4/2016

Disclosure. State of Connecticut Naloxone Training Program. Introduction. Objectives. Epidemiology. Background 3/4/2016 State of Connecticut Naloxone Training Program Developed by: Department of Consumer Protection Drug Control Division Connecticut Pharmacists Association Department of Mental Health and Addiction Services

More information

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013

Outline. Interventions to Reduce Opioid Overdose State of the Art 9/23/2013 Interventions to Reduce Opioid Overdose State of the Art Caleb J. Banta Green PhD MPH MSW Research Scientist Alcohol and Drug Abuse Institute Affiliate Asst. Professor School of Public Health University

More information

BREAKING THE CYCLE. Clermont County s 2015 Response to the Opiate Epidemic

BREAKING THE CYCLE. Clermont County s 2015 Response to the Opiate Epidemic BREAKING THE CYCLE Clermont County s 2015 Response to the Opiate Epidemic SPONSORED BY: Clermont County Mental Health & Recovery Board and Clermont County Public Health Understanding the Opiate Epidemic

More information

Collaborative Drug Therapy Agreement for Naloxone Medication in Opioid Overdose Reversal

Collaborative Drug Therapy Agreement for Naloxone Medication in Opioid Overdose Reversal Collaborative Drug Therapy Agreement for Naloxone Medication in Opioid Overdose Reversal I,, MD, a licensed health care provider authorized to prescribe medication in the State of Washington, delegate

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

Physician Information. Answers to Frequently Asked Questions

Physician Information. Answers to Frequently Asked Questions Page 31 Physician Information Answers to Frequently Asked Questions Who is qualified to prescribe SUBOXONE or SUBUTEX? Physicians who: Meet one or more of the following training requirements Hold a subspecialty

More information

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing

More information

Iowa Governor s Office of Drug Control Policy

Iowa Governor s Office of Drug Control Policy Iowa Governor s Office of Drug Control Policy medicines or take them in a manner not prescribed, we increase the risk of negative effects. It is estimated that over 35 million Americans are ages 65 and

More information

Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010

Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Prescription Opioid Use and Opioid-Related Overdose Death TN, 2009 2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence Service Officer Tennessee Department of

More information

CDC s Prevention Efforts to Address Prescription Opioid Epidemic

CDC s Prevention Efforts to Address Prescription Opioid Epidemic CDC s Prevention Efforts to Address Prescription Opioid Epidemic Jan Losby, PhD, MSW Lead, Prescription Drug Overdose Health Systems and State Support Team Division of Unintentional Injury Prevention NASBO

More information

Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center

Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center PRESCRIPTION DRUG ABUSE, HEROIN ADDICTION AND OVERDOSE PREVENTION IN RURAL COMMUNITIES Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Gateway Rehabilitation Center Number of Deaths from Drug Overdoses

More information

Naloxone for Opioid Overdose: FAQs

Naloxone for Opioid Overdose: FAQs PL Detail-Document #310702 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER July 2015 Naloxone for Opioid

More information

DANE COUNTY OPIATE OVERDOSE SURVEY (10/12 1/13) & FOCUS GROUP (1/13)

DANE COUNTY OPIATE OVERDOSE SURVEY (10/12 1/13) & FOCUS GROUP (1/13) DANE COUNTY OPIATE OVERDOSE SURVEY (10/12 1/13) & FOCUS GROUP (1/13) Stop the Drug Overdose Epidemic Initiative Summit Reunion April 8, 2013 Lisa Bullard Cawthorne, MS, MPH, PHMDC Suryadewi Edi Nugraheni,

More information

Populations at risk for opioid overdose

Populations at risk for opioid overdose Populations at risk for opioid overdose Len Paulozzi, MD, MPH Division of Unintentional Injury Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention April

More information

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org

EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org EXPLORING NALOXONE UPTAKE AND USE PUBLIC MEETING July 01 02, 2015 Fred Wells Brason II fbrason@projectlazarus.org Disclosures Project Lazarus Zogenix Charitable Contribution 2015 Kaléo Charitable Contribution

More information

BSTA Anaphylaxis /Stock Epinephrine Policy

BSTA Anaphylaxis /Stock Epinephrine Policy BSTA Anaphylaxis /Stock Epinephrine Policy (Severe Allergic Reaction) It is the policy of Beehive Science and Technology Academy to provide at least two (2) doses of auto- injectable epinephrine (hereinafter

More information

Prior Authorization Guideline

Prior Authorization Guideline Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San

More information

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E

ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use

More information

Overdose Education in Medical Settings

Overdose Education in Medical Settings Overdose Education in Medical Settings Where is the patient at as far as overdose? Ask your patients whether they have overdosed, witnessed an overdose or received training to prevent, recognize, or respond

More information

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion Angela Huskey, PharmD, CPE Case Bill is a 47 year old man with a history of low back pain and spinal stenosis Not a real

More information

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse

More information

Heroin Addiction. Kim A. Drury RN, MSN

Heroin Addiction. Kim A. Drury RN, MSN Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services

More information

D R A F T SUMMARY. prescription monitoring information submitted under ORS 431A.860 to

D R A F T SUMMARY. prescription monitoring information submitted under ORS 431A.860 to LC 0 Regular Session // (SCT/ps) D R A F T SUMMARY Requires Oregon Health Authority to disclose prescription monitoring information to practitioner or pharmacist or member of practitioner s or pharmacist

More information

Opioid Overdose and Intranasal Naloxone Training for Law Enforcement

Opioid Overdose and Intranasal Naloxone Training for Law Enforcement Opioid Overdose and Intranasal Naloxone Training for Law Enforcement Participant Manual Prepared by NYS Division of Criminal Justice Services NYS Department of Health NYS Office of Alcoholism and Substance

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008 PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease

More information

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational

More information

Medication Assisted Treatment

Medication Assisted Treatment Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice

More information

Prescription Drug Abuse

Prescription Drug Abuse Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us

More information

The Professional Practice Committee Douglas E. Lentivech. September 8, 2015 SUMMARY

The Professional Practice Committee Douglas E. Lentivech. September 8, 2015 SUMMARY THE STATE EDUCATION DEPARTMENT / THE UNIVERSITY OF THE STATE OF NEW YORK / ALBANY, NY 12234 TO: FROM: SUBJECT: DATE: The Professional Practice Committee Douglas E. Lentivech Proposed Amendment to Section

More information

Opiate Abuse and Mental Illness

Opiate Abuse and Mental Illness visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?

More information

Rx and Heroin Abuse :Taking Action

Rx and Heroin Abuse :Taking Action Rx and Heroin Abuse :Taking Action Dan Hicks, Manager, Prevention Services November 21, 2014 Page 1 Rx Abuse & Heroin: Increasing Awareness Young people are abusing prescription drugs at alarming rates.

More information

Allyse Adams PC, LICDC Oriana House, Inc.

Allyse Adams PC, LICDC Oriana House, Inc. Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In

More information

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose

What is an opioid? Why address opioid use in your county? Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose Support the Prevention Agenda by Preventing Non-Medical Prescription Opioid Use and Overdose What is an opioid? Opioids are a type of pain-relief medication. According to the National Institute on Drug

More information

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery

Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by

More information

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015

Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid

More information

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013

Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi. Signe Shackelford, MPH Policy Analyst November 19, 2013 Prescription Drugs: Impacts of Misuse and Accidental Overdose in Mississippi Signe Shackelford, MPH Policy Analyst November 19, 2013 Center for Mississippi Health Policy Independent, non-profit organization

More information

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER November 17, 2015 Today s Speakers Karmen Hanson, Program Manager, NCSL Cynthia Reilly, Director,

More information

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE

More information

Community based opioid overdose prevention: the role of naloxone. William Matthews, Physician Assistant Harm Reduction Coalition New York, NY

Community based opioid overdose prevention: the role of naloxone. William Matthews, Physician Assistant Harm Reduction Coalition New York, NY Community based opioid overdose prevention: the role of naloxone William Matthews, Physician Assistant Harm Reduction Coalition New York, NY Drug poisoning death rates by manner of death, US, 1979 2002

More information

the facts about NALTREXONE

the facts about NALTREXONE the facts about NALTREXONE for Treatment of Opioid Addiction It s not like I woke up one day when I was young and told myself, I wanna be a drug addict. I wanna ruin my life and ruin the lives of those

More information

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.

More information

Medication-Assisted Addiction Treatment

Medication-Assisted Addiction Treatment Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling

More information

Epinephrine Auto Injector Interim Policy (Amended March 12, 2008)

Epinephrine Auto Injector Interim Policy (Amended March 12, 2008) Epinephrine Auto Injector Interim Policy (Amended March 12, 2008) Pursuant to the authority conferred by N.J.S.A. 26:2K-47.1, et seq., the Department of Health and Senior Services (the Department) shall

More information

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive. Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.

More information

CHAPTER 10. 1. Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows:

CHAPTER 10. 1. Section 3 of P.L.2013, c.46 (C.24:6J-3) is amended to read as follows: CHAPTER 10 AN ACT concerning overdose prevention and sterile syringe access programs, and amending P.L.2006, c.99 and P.L.2013, c.46. BE IT ENACTED by the Senate and General Assembly of the State of New

More information

Section 400: Code # 453.4R

Section 400: Code # 453.4R Section 400: Code # 453.4R Administering Medication Conditions for Administering Prescription Drugs Except as otherwise specifically provided by law, a school bus driver, employee, or volunteer that has

More information

Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon

Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon Northwest Primary Care Practitioners Presentation Tackling the Opioid Epidemic in Oregon Dwight Holton Chief Executive Officer Lines for Life 971-244-1370 DwightH@linesforlife.orrg Page 1 of 21 14 Masters

More information

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised:

BROCKTON AREA MULTI-SERVICES, INC. MEDICAL PROCEDURE GUIDE. Date(s) Reviewed/Revised: Page 1 of 5 PROCEDURE FOR: MAP-certified staff and RN/LPN MAP-certified staff are to be trained in the use of epinephrine administration via pre-filled autoinjector devices(s) annually. Certified staff

More information

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director

Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Heroin Addiction and Overdose: What Can We Do to Address This Growing Problem? Nora D. Volkow, M.D. Director Illicit Drugs Marijuana Prescription Drug Misuse/Abuse is a Major Problem in the US Current

More information

Naloxone: Overview, Criminal Justice and other Special Settings

Naloxone: Overview, Criminal Justice and other Special Settings Naloxone: Overview, Criminal Justice and other Special Settings Ingrid Binswanger, MD, MPH, MS Division of General Internal Medicine Affiliated Member, Division of Substance Dependence University of Colorado

More information

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate

More information

Medication is not a part of treatment.

Medication is not a part of treatment. Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained

More information

Prescriber Behavior, Pain Treatment and Addiction Treatment

Prescriber Behavior, Pain Treatment and Addiction Treatment Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy

More information

Prescription Drug Abuse and Overdose: Public Health Perspective

Prescription Drug Abuse and Overdose: Public Health Perspective Prescription Drug Abuse and Overdose: Public Health Perspective [Residency educators may use the following slides for their own teaching purposes.] CDC s Primary Care and Public Health Initiative October

More information

UNIT VIII NARCOTIC ANALGESIA

UNIT VIII NARCOTIC ANALGESIA UNIT VIII NARCOTIC ANALGESIA Objective Review the definitions of Analgesic, Narcotic and Antagonistic. List characteristics of Opioid analgesics in terms of mechanism of action, indications for use and

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County Cuyahoga County March 2014, Issue 1 Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County According to the Ohio Department of Health (ODH), between 1999 and 2011,

More information

OPIOID OVERDOSE PREVENTON

OPIOID OVERDOSE PREVENTON 1 OPIOID OVERDOSE PREVENTON Zena Hyman, DNS, ANP-BC October 4, 2015 2 Special Thanks and Recognition to: Office of Alcoholism and Substance Abuse Services New York State Department of Health Harm Reduction

More information

What Parents Need to Know

What Parents Need to Know What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to

More information